Chronic Pain Management in Senior Dogs: Multimodal Therapy Guide

Last updated: May 16, 2026

Why Chronic Pain Management in Senior Dogs Has Changed

Chronic pain management in senior dogs has evolved significantly in the last decade. The old approach — a single NSAID for life, raise the dose if it stops working — has been replaced by a multimodal model that combines several drug classes at modest doses, layers in non-drug therapies, and adapts as comorbidities emerge. The result is better pain control, fewer side effects, and longer comfortable lifespans for older dogs.

Most senior dogs in pain are dealing with osteoarthritis (the broad dog arthritis overview and the arthritis in dogs guide walk through diagnosis and staging). Spinal disease, cancer pain, soft-tissue injury, and dental pain layer on top in some patients. The strategy is the same regardless of source: identify all pain generators, treat each one, and re-evaluate every 4-12 weeks.

This article reviews the components of a modern multimodal plan. It does not give you specific doses or substitute for veterinary direction; chronic pain management lives at the intersection of drug pharmacology, the individual dog’s organ function, and lifestyle factors only your vet can integrate.

Recognizing Pain in a Stoic Senior Dog

Dogs in chronic pain rarely cry out. The signs are subtle and accumulate slowly: reluctance to climb stairs, slower to rise from rest, shorter walks, change in posture (roached back, lowered head), reduced play, decreased appetite, restlessness or repositioning at night, irritability with handling, lip licking when touched in a sore area, and decreased social engagement. Owners often describe the change in retrospect — “she has been slowing down for a year now” — once treatment kicks in and the dog returns to a younger version of herself.

Validated owner-completed pain scales — the Liverpool Osteoarthritis in Dogs (LOAD), the Helsinki Chronic Pain Index, the Canine Brief Pain Inventory — translate observations into trackable scores. Use one of these tools at the first chronic-pain appointment and at every recheck. Trend lines guide medication adjustments better than spot impressions.

Video matters. A 30-second clip of your dog rising from a down, walking down a flight of stairs, or jumping onto the couch tells your veterinarian things they cannot see in an exam room.

NSAIDs — The Foundation, with Caveats

Non-steroidal anti-inflammatories remain the foundation of canine chronic pain management. Carprofen for dogs, Galliprant for dogs, Onsior for dogs, meloxicam, and deracoxib are the most-used options. Each has slightly different pharmacology; not every dog responds equally to every NSAID, and switching when one is partially effective is a reasonable strategy.

Senior NSAIDs require careful baseline and periodic monitoring of kidney values, liver enzymes, and clinical hydration. Concurrent disease shifts the calculus. Dogs with chronic kidney disease or congestive heart failure need careful NSAID selection and dose; some are safer than others. Galliprant, which targets the EP4 receptor specifically, is sometimes a better option in dogs where standard NSAIDs are contraindicated.

Never combine an NSAID with corticosteroids. Never combine two NSAIDs. Always wash out before switching from one NSAID to another. GI side effects (vomiting, diarrhea, anorexia, melena) warrant immediate phone contact with your vet.

Gabapentin — Adjunctive Pain Control That Earns Its Place

Gabapentin for dogs is widely used as an adjunct for chronic pain, particularly when there is a neuropathic component (nerve-root compression, radiculopathy from disc disease, post-surgical neuropathic pain). It is often added to an NSAID rather than replacing one. Sedation is the most common side effect, especially at the start; many dogs adjust within a week.

Gabapentin doses are adjusted by weight and renal function, not on a one-size schedule. Senior dogs with reduced kidney function need lower doses or longer dosing intervals. The drug is not a sedative in the traditional sense; it modifies how the nervous system processes pain signals over time.

For breakthrough pain, gabapentin can be dosed strategically before activities you know will be painful (a long walk, a vet visit, a longer car trip). Working with your veterinarian on a “scheduled plus as-needed” plan is more useful than chasing pain after the fact.

Amantadine, Tramadol, and Other Adjuncts

Amantadine, originally an antiviral, has analgesic properties as an NMDA-receptor antagonist. It is added to multimodal plans for dogs with persistent pain on NSAIDs plus gabapentin and is well tolerated long-term in most patients. Side effects are uncommon at therapeutic doses.

Tramadol for dogs has fallen out of favor as a chronic-pain monotherapy because canine metabolism converts much less of the drug into the active opioid metabolite than human metabolism does. It still has a role in some patients, particularly as a short-course bridge after a flare or as part of palliative care. Discussion with your vet about whether tramadol fits your dog’s plan is worth having explicitly.

For severe or end-of-life pain, sustained-release opioids (transdermal fentanyl, oral methadone in some settings) are added under veterinary supervision. The hospice-pain conversation often involves a cardiology, oncology, or internal medicine specialist alongside the primary vet.

Joint-Specific Therapies — Adequan and the Injectable Lane

Adequan for dogs (polysulfated glycosaminoglycan) is a series of injections given intramuscularly that targets cartilage health and joint inflammation. The standard induction protocol is twice weekly for four weeks; many dogs maintain on monthly injections thereafter. Adequan often works best as one component of a multimodal plan rather than alone, but some dogs respond meaningfully when added.

Other injectable approaches include intra-articular hyaluronic acid, intra-articular corticosteroid (rare and case-specific), and platelet-rich plasma (PRP) or stem-cell therapy at specialty practices. Evidence quality varies; ask your veterinarian about which therapies have current support and which are still under investigation.

Frunevetmab (a monoclonal antibody used in cats — see the chronic pain management in senior cats piece) has a canine analog (bedinvetmab/Librela), an anti-NGF monoclonal antibody given as a monthly injection. Adoption has been rapid in some markets; speak with your veterinarian about availability and fit for your specific dog.

Joint Supplements — What the Evidence Supports

Glucosamine-chondroitin combination supplements like Cosequin for dogs and Dasuquin for dogs are widely used as adjuncts. Evidence for symptom benefit is mixed but signals are positive in many studies; side effects are rare. They are not first-line therapy alone but a reasonable layer in a broader plan. The dog joint supplements overview, the dog joint supplements guide, and the joint supplements for dogs: what works piece walk through the choices.

Omega-3 fatty acids (EPA/DHA from fish oil) have anti-inflammatory effects relevant to joint pain and have stronger evidence than glucosamine alone. Veterinary-grade fish oil dosed by weight is generally well tolerated. Green-lipped mussel is another commonly used supplement with modest evidence.

Avoid mixing many supplements with overlapping ingredients; doubling up on a glucosamine product or stacking multiple omega-3 sources without your vet’s guidance can shift dosing into territory that has not been studied.

Non-Drug Modalities — Rehab, Acupuncture, Laser, Weight

Weight management is the highest-yield non-drug intervention. A senior dog 10-15% above ideal body weight has significantly more mechanical load on every step. Veterinary-prescribed weight-loss diets, controlled portions, and gentle activity are more effective than pain medication for some dogs. Body condition score 4-5/9 is the goal.

Canine rehabilitation (the veterinary equivalent of physical therapy) includes underwater treadmill, range-of-motion work, balance and proprioception exercises, and home programs. Certified canine rehabilitation practitioners (CCRP) and certified canine rehabilitation therapists (CCRT) work alongside your veterinarian. Many senior dogs gain meaningful function from rehab even when surgery is not on the table.

Veterinary acupuncture (often offered by primary vets with additional training) and therapeutic laser (low-level laser therapy, LLLT) have moderate evidence for pain reduction and are well tolerated. Both are layered onto medical management, not substitutes. Mobility aids (the orthopedic beds for senior dogs, ramps for senior dogs, and dog mobility aids and wheelchairs resources) reduce daily pain by removing the situations that produce it.

Cardiac and Renal Comorbidity — When NSAIDs Are Off the Table

Senior dogs commonly have CKD, CHF, or both. NSAIDs reduce renal blood flow and can precipitate or worsen kidney injury, especially in dehydrated or hypotensive states. Dogs with significant heart disease or kidney disease often cannot use NSAIDs safely; their multimodal plan shifts toward gabapentin, amantadine, opioids, joint injectables, supplements, rehab, weight management, and acupuncture.

This is one of the practical drivers of the multimodal model: when the strongest single drug class is unavailable, the cumulative effect of three or four moderate interventions still adds up to good pain control. Working with an ACVIM Internal Medicine specialist alongside your primary vet is often valuable for these cases.

The senior pet multi-organ disease management framework expands on coordinating pain control with cardiac, renal, and endocrine therapy. Many of the trickiest senior cases live in this overlap.

The Recheck Cadence That Catches Problems Early

Chronic pain plans are not “set it and forget it.” Standard cadence is a recheck four weeks after starting or changing a medication, then every three months once stable. Bloodwork (CBC, chemistry, urinalysis) is repeated every six months for dogs on long-term NSAIDs, more often for ASA III patients.

Track three things between visits: a validated pain score (LOAD, Helsinki, CBPI), a video clip showing typical movement, and a notebook of observations including appetite, sleep, GI signs, and behavior changes. Bringing this data to the recheck makes the appointment significantly more productive.

If your dog’s plan has stopped working, talk to your vet before stopping or doubling medications. Sometimes the answer is a new drug class; sometimes it is a dose adjustment; sometimes it is a referral to a rehab specialist or pain-medicine veterinarian. The framework is iterative, not static.

Frequently Asked Questions

Can I give my senior dog human pain medications?

No. Ibuprofen, acetaminophen, naproxen, and aspirin all carry serious risks for dogs (GI ulceration, kidney injury, liver toxicity). Stick with veterinary-prescribed medications. If you suspect accidental ingestion of a human pain medication, contact your vet, the ASPCA APCC at 888-426-4435, or the Pet Poison Helpline at 855-764-7661 immediately.

How long can my dog stay on an NSAID?

Many senior dogs take an NSAID for years with appropriate monitoring. Bloodwork every 6 months, attention to kidney values, hydration, and concurrent disease, and prompt response to GI signs all support long-term use. Some dogs are cycled on and off; others stay on continuously. Your vet individualizes the plan.

What is the role of CBD in senior dog pain?

CBD is increasingly studied as an adjunct for chronic pain in dogs. Evidence is preliminary; some studies show modest benefit. Quality control and labeling accuracy in CBD products vary widely. Discuss with your veterinarian before adding any CBD product to your dog’s plan, especially if other medications are on board.

Is my dog’s pain making them seem confused or grumpy?

Untreated chronic pain shifts behavior — irritability, withdrawal, sleep disruption, decreased engagement. Some dogs labeled as “demented” or “depressed” turn out to have pain. The differential between cognitive dysfunction and pain-driven change is worth working up; treating the pain often resolves the apparent behavioral changes.

When should I consider hospice or palliative care?

When pain becomes hard to control despite a thoughtful multimodal plan, when comorbidities limit drug options, or when the disease is progressing toward end-of-life, the conversation shifts. The hospice care decision framework and the palliative care for dogs resource walk through that pivot.